BIOMOLECULAR ASPECTS AND UPDATE ON TREATMENT OF CEREBRAL MALARIA

Machlusil Husna, Bowo Hery Prasetyo
  MNJ, pp. 79-88  

Abstract


Malaria is still becoming a health problem in the world and in Indonesia. Cerebral malaria is one of many features of severe and life threatening malaria. Many hypotheses underlying the pathophysiology of cerebral malaria have been disclosed, but the one that evolved nowdays is the hyphotesis of mechanical, permeability, humoral, and MMPs. These hypotheses proposed about biomolecular aspects of cerebral malaria and the mechanism is still not well understood. The understanding of this pathophysiology will aid the treatment of cerebral malaria. Current basic treatment of cerebral malaria is the ACT (artemisinin base combination treatment) drugs, supportive treatment and the management of its complications which is indispensable. Many research has been conducted and still in progress for finding the best optimal treatment.


Keywords


biomolecular; cerebral malaria; therapy update

Full Text:

PDF

References


Scheld MW, Whitley RJ, Marra CM. Infections of The Central Nervous System. Fourth edition. Chapter 42 Cerebral Malaria. Wolter Kluwer. 2014. 729-742.

Moxon CA, Heyderman RS, Wassmer SC. Review: Dysregulation of coagulation in cerebral malaria. Molecular & biochemical Parasitology 166. 2009. 99-108.

Bilal M, Khan Y, Naeem A. Effectiveness of Intravenous Artesunate in the Treatment of Cerebral Malaria Due to Falciparum Malaria. Ann. Pak. Inst. Med. Sci. 2014; 10(2): 71-74.

Ngoungou EB, Preux PM. Supplement-Central Nervous System infections. Cerebral malaria and epilepsy. Epilepsia. 2008. Suppl. 49.19-24.

Dale P, Sipe N, Anto S, Hutajulu B, Ndoen E, Papayungan M, Saikhu A, Prabowa Y.T. Malaria In Indonesia: a Summary of Recent Research into its Environmental Relationships. Southeast Asian J Trop Med Public Health. 2005; 36(1): 1-11.

Elyazar IRF, Hay SI, Baird JK. Malaria Distribution, Prevalence, Drug Resistance and Controls in Indonesia. Advances in Parasitology. 2011;74: 41-175.

Polimeni M, Prato M. Review: Host Matrix Metalloproteinases in Cerebral Malaria: New Kids on the Block Against Blood–Brain Barrier Integrity?. Fluids and Barriers of the CNS. 2014, 11:1.

Harijanto P. Eliminasi malaria pada era desentralisasi. Pusat data dan informasi. Direktorat pengendalian penyakit bersumber binatang. Buletin Jendela Data & Informasi Kesehatan Kemenkes RI. 2011. Volume 1. Triwulan 1.

WHO. Guidelines for the treatment of malaria. WHO library cataloguing in publication data. 2010. 2nd edition.

White NJ, Breman JG. Malaria In: Braunwald E., et al. Harrison’s Principles of Internal Medicine. 17th Edition. New York: McGrawHill Inc. 2008. p 1280-3.

Lee KS, Cox-Singh J, Singh B. Morphological features and differential counts of Plasmodium knowlesi parasites in naturally acquired human infections. Malaria Journal. 2009, 8:73.

Idro R, Jenkins NE, Newton NE. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4:82740.

Mitsuda H. Malaria control as a global challenge. Mataram University Press; 2009.

Haryanto PN, Nugroho A, Gunawan CA. Malaria dari Molekuler ke Klinis. Edisi 2. Jakarta, 2010.

Milner DA, Daily J, Baron EL. Pathogenesis of malaria. http://www.uptodate.com 2011. Diakses pada 10 Oktober 2014.

Centers for Disease Control and Prevention (CDC). Malaria. Biology. 2012. Full text at http://www.cdc.gov/Globalhealth.

Harijanto P. Malaria, dalam : Buku ajar Ilmu Penyakit Dalam. Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI. Jakarta. 2006. 1754-1766.

Zulkarnain I, Setiawan B. Malaria berat dalam Buku Ajar Ilmu Penyakit Dalam. Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI. Jakarta. 2006.1767-1770.

Kakkilaya BS. Central Nervus System Involvement in P. Falciparum Malaria. Last update. June 9, 2009. http://www.malariasite.com/malaria/complication 3.htm. Diakses pada 31 Desember 2014.

Niikura M, Kamiya S, Nakane A, Kita K, Kobayashi F. IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites. International Journal of Parasitology. 2010. 40 :101-108.

Runtuwene T. Clinical aspect and management of cerebral malaria. Infeksi pada system saraf. Kelompok Studi Neuro Infeksi. 2011. 103-117.

Chen Q, Schlichtherle M, Wahlgren. Molecular Aspects of Severe Malaria. Clinical Microbiology Reviews. July 2000; 13 (3); 439450. Full text at http://cmr.asm.org/cgi/content/full/13/3/439

Kemkes RI. Pedoman Tata Laksana Malaria. 2012.

Maloba B, Moonasar D, Furumele T, Misiani E, Benson F, Zeeman H, Willers N, Groepe MA. Guidelines for the Treatment of Malaria in South Africa. The National Departement of Health. 2009.

Birbeck GL, Molyneux ME, Kaplan PW, Seydel KB, Chimalizeni YF, Kawaza K, Taylor TE. Blantyre Malaria Project Epilepsy Study (BMPES) of Neurological outcomes in retinopathy-positive Paediatric Cerebral Malaria survivors: a prospective cohort study. Lancet Neuro J. 2010: 9:1173-81

McPhee SJ, Papadakis MA. Current Medical Diagnosis & Treatment. Fourty-eighth edition. USA: McGraw-Hill Companies, Inc. 2009.

Wasnik PN, et al. Study of clinical profile of Falciparum malaria in a tertiary referral centre in central India. JAPI. 2012;60:33-6.

WHO. A Practical Handbook. Management of Severe Malaria. WHO. Third edition. 2012.

Crawley J, Smith S, Muthinji P, Marsh K, Kirkham F. Electroencephalographic and clinical features of cerebral malaria. Arch Dis Child. 2001. 84: 247-253.

Mohanty S, Taylor TE, Kampondeni S, Potchen MJ, Panda P, Majhi M, Mishra SK, Wassmer S. Magnetic resonance imaging during life: the key to unlock cerebral malaria pathogenesis ?. Malaria Journal. 2014.13:276.

Maude RJ, Barkhof F, Hassan MU, Ghose A, Hossain A, et al. Magnetic resonance imaging of the brain in adults with severe falciparum malaria. Malaria Journal. 2014. 13: 177.

Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004; 2: CD000363.

Kawai S, Sugiyama M. Imaging analysis of the brain in primate model of cerebral malaria. Acta Tropica 114. 2010. 152-156.

Engwerda C, Belnoue E, Grűner AC, Renia L. Experimental models of cerebral malaria. Current Trends in Immunology. 2005; 297:103-43.

Bellet D, Chabra R, van Doom R, et al. The Blood Brain Barrier (BBB). Springer-Verlag Berlin. 2014.

Razankadrainibe, R., Pelleau, S., Grau, G.E., Jambou, R., Review: Antigen presentation by endothelial cells: what role in the pathophysiology of malaria?. Trends in Parasitology. 2012. Vol.28. No.4.

Piguet PF, Kan CD, Vesin C. Role of the Tumor Necrosis Factor Receptor 2 (TNFR2) in Cerebral Malaria in Mice. Laboratory Investigation. 2002; 82(9):1155-64.

Clark IA, Budd AC, Alleva LM, Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malaria Journal. 2006; 5:85.

Chandrasekharan UM, et al. Tumor necrosis factor-α (TNF-α) receptor-II is required for TNF-α-induced leukocyte-endothelial interaction in vivo. BLOOD 2007; 109(5):1938-44.

Dondorp AM. Patophysiology, clinical presentation and treatment of cerebral malaria. Neurology Asia. 2005;10:67-77.

Tjahjani S, Khiong K. Potensi Buah Merah Sebagai Antioksidan dalam Mengatasi Malaria Berghei pada Mencit Strain Balb/C. Majalah Kedokteran Indonesia. 2010. Volum: 60. No.12.

Schumann R. Malarial fever: Hemozoin is involved but Toll-free. PNAS 6 february. 2007; 104 (6) : 1743-1744. Full text at http://www.pnas.org/content/104/6/1743.full. pdf+html.

Kemkes RI. Buku Saku Penatalaksanaan Kasus Malaria. 2013.

Anvikar A, Arora U, Chattopadhya D, Das B, Dash AP, Dhariwal AC, et al. Guidelines for Diagnosis and Treatment of Malaria in India. National Institute of Malaria Research ch. June 2011.

Abay ET, Westuizen JH, Swart KJ, Gibhard L, Lawrence N, Dambuza N, Wilhelm A, Pravin K, Wiesner L. E. Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model. Malaria Journal. 2015. 14:8.

Liu L, Huq S, Xu W. Targeting Cyclooxygenase and Nitric Oxide Pathway Cross-Talk: A New Signal Transduction Pathway for Developing More Effective Anti- Inflammatory Drugs. Current Signal Transduction Therapy. 2009; 4: 66-75.

Balam S, Olugbile S, Servis C, et al. Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains. Malaria Journal. 2014. 13:510.


Refbacks

  • There are currently no refbacks.